Biosafety of Mesoporous Silica Nanoparticles

Careful analysis of any new nanomedicine device or disposal should be undertaken to comprehensively characterize the new product before application, so that any unintended side effect is minimized. Because of the increasing number of nanotechnology-based drugs, we can anticipate that regulatory auth...

Descripción completa

Detalles Bibliográficos
Autores principales: Rascol, Estelle, Pisani, Cédric, Dorandeu, Christophe, Nyalosaso, Jeff L., Charnay, Clarence, Daurat, Morgane, Da Silva, Afitz, Devoisselle, Jean-Marie, Gaillard, Jean-Charles, Armengaud, Jean, Prat, Odette, Maynadier, Marie, Gary-Bobo, Magali, Garcia, Marcel, Chopineau, Joël, Guari, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352691/
https://www.ncbi.nlm.nih.gov/pubmed/31105244
http://dx.doi.org/10.3390/biomimetics3030022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352691/
https://www.ncbi.nlm.nih.gov/pubmed/31105244
http://dx.doi.org/10.3390/biomimetics3030022

Ejemplares similares